| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/07/2023 | 24.69% | Morgan Stanley | $12 → $15 | Maintains | Equal-Weight |
| 11/03/2023 | 66.25% | Cantor Fitzgerald | $15 → $20 | Maintains | Overweight |
| 11/03/2023 | 8.06% | Keybanc | $12 → $13 | Maintains | Overweight |
| 10/23/2023 | -0.25% | Morgan Stanley | $13 → $12 | Maintains | Equal-Weight |
| 10/19/2023 | 8.06% | B of A Securities | → $13 | Reinstates | → Buy |
| 08/04/2023 | 24.69% | Needham | $16 → $15 | Maintains | Buy |
| 08/04/2023 | -8.56% | Piper Sandler | $10 → $11 | Maintains | Neutral |
| 06/01/2023 | 33% | Needham | → $16 | Reiterates | Buy → Buy |
| 05/05/2023 | 132.75% | Citigroup | $32 → $28 | Maintains | Buy |
| 05/04/2023 | 33% | Cantor Fitzgerald | $18 → $16 | Maintains | Overweight |
| 05/04/2023 | 33% | Needham | → $16 | Reiterates | → Buy |
| 05/04/2023 | -16.87% | Piper Sandler | $12 → $10 | Maintains | Neutral |
| 05/04/2023 | -0.25% | Keybanc | $15 → $12 | Maintains | Overweight |
| 04/05/2023 | -0.25% | Piper Sandler | → $12 | Reiterates | → Neutral |
| 03/31/2023 | 16.38% | Morgan Stanley | $15 → $14 | Maintains | Equal-Weight |
| 02/15/2023 | 49.63% | Truist Securities | $20 → $18 | Maintains | Buy |
| 02/15/2023 | 24.69% | Morgan Stanley | $16 → $15 | Maintains | Equal-Weight |
| 02/15/2023 | 24.69% | Baird | $16 → $15 | Maintains | Outperform |
| 02/15/2023 | 49.63% | Cantor Fitzgerald | $20 → $18 | Maintains | Overweight |
| 02/15/2023 | 33% | Needham | $17 → $16 | Maintains | Buy |
| 02/15/2023 | -0.25% | Piper Sandler | $14.5 → $12 | Maintains | Neutral |
| 02/15/2023 | 24.69% | Keybanc | $19 → $15 | Maintains | Overweight |
| 11/18/2022 | 57.94% | Keybanc | $16 → $19 | Maintains | Overweight |
| 11/04/2022 | 20.53% | Piper Sandler | $13 → $14.5 | Maintains | Neutral |
| 11/03/2022 | 16.38% | JP Morgan | $16 → $14 | Maintains | Neutral |
| 08/04/2022 | 8.06% | Piper Sandler | $11 → $13 | Maintains | Neutral |
| 08/04/2022 | 33% | Keybanc | $15 → $16 | Maintains | Overweight |
| 07/19/2022 | 33% | Morgan Stanley | $17 → $16 | Maintains | Equal-Weight |
| 07/18/2022 | -8.56% | Piper Sandler | $13 → $11 | Downgrades | Overweight → Neutral |
| 05/31/2022 | 24.69% | Jefferies | $11 → $15 | Maintains | Hold |
| 05/05/2022 | 41.31% | Morgan Stanley | $24 → $17 | Maintains | Equal-Weight |
| 05/05/2022 | 41.31% | Needham | $25 → $17 | Maintains | Buy |
| 05/05/2022 | 8.06% | Piper Sandler | $22 → $13 | Maintains | Overweight |
| 05/05/2022 | 24.69% | Keybanc | $20 → $15 | Maintains | Overweight |
| 03/30/2022 | 82.88% | Cantor Fitzgerald | → $22 | Initiates Coverage On | → Overweight |
| 03/18/2022 | 149.38% | Berenberg | → $30 | Initiates Coverage On | → Buy |
| 03/17/2022 | 149.38% | Berenberg | → $30 | Initiates Coverage On | → Buy |
| 02/10/2022 | 107.81% | Needham | $37 → $25 | Maintains | Buy |
| 02/10/2022 | 82.88% | Piper Sandler | $24 → $22 | Maintains | Overweight |
| 02/03/2022 | 107.81% | Keybanc | $37 → $25 | Maintains | Overweight |
| 01/13/2022 | 99.5% | Piper Sandler | $34 → $24 | Maintains | Overweight |
| 12/14/2021 | 132.75% | JP Morgan | $31 → $28 | Maintains | Neutral |
| 12/09/2021 | 182.63% | Piper Sandler | $37 → $34 | Maintains | Overweight |
| 11/23/2021 | 199.25% | Morgan Stanley | → $36 | Initiates Coverage On | → Equal-Weight |
| 11/23/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 11/23/2021 | 274.06% | Citigroup | → $45 | Initiates Coverage On | → Buy |
| 11/23/2021 | 232.5% | B of A Securities | → $40 | Initiates Coverage On | → Buy |
| 11/23/2021 | 249.13% | Truist Securities | → $42 | Initiates Coverage On | → Buy |
| 11/23/2021 | 207.56% | Keybanc | → $37 | Initiates Coverage On | → Overweight |
| 11/23/2021 | 166% | Jefferies | → $32 | Initiates Coverage On | → Hold |
| 11/23/2021 | 207.56% | Needham | → $37 | Initiates Coverage On | → Buy |
| 11/23/2021 | 249.13% | Baird | → $42 | Initiates Coverage On | → Outperform |
| 11/23/2021 | 190.94% | JP Morgan | → $35 | Initiates Coverage On | → Neutral |
| 11/23/2021 | 207.56% | Piper Sandler | → $37 | Initiates Coverage On | → Overweight |
What is the target price for Udemy (UDMY)?
The latest price target for Udemy (NASDAQ: UDMY) was reported by Morgan Stanley on November 7, 2023. The analyst firm set a price target for $15.00 expecting UDMY to rise to within 12 months (a possible 24.69% upside). 23 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Udemy (UDMY)?
The latest analyst rating for Udemy (NASDAQ: UDMY) was provided by Morgan Stanley, and Udemy maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Udemy (UDMY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Udemy, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Udemy was filed on November 7, 2023 so you should expect the next rating to be made available sometime around November 7, 2024.
Is the Analyst Rating Udemy (UDMY) correct?
While ratings are subjective and will change, the latest Udemy (UDMY) rating was a maintained with a price target of $12.00 to $15.00. The current price Udemy (UDMY) is trading at is $12.03, which is within the analyst's predicted range.